Several factors were significantly associated with OS, including molecular subtype, positive hormone receptor status (ER+ and PR+), nuclear grade, tumor size, axillary lymph node dissection, recurrence, prognostic stage (II–IV), and YY1 expression. Here, ESR1 is linked to neoplasm.